ziconotide and Mental-Disorders

ziconotide has been researched along with Mental-Disorders* in 1 studies

Other Studies

1 other study(ies) available for ziconotide and Mental-Disorders

ArticleYear
Blockade of presynaptic voltage-gated calcium channels in the medial prefrontal cortex of neonatal rats leads to post-pubertal alterations in locomotor behavior.
    Brain research, 2006, Apr-14, Volume: 1083, Issue:1

    Although the etiology of neurodevelopmental mental disorders remains obscure, converging lines of evidence using animal modeling suggest a critical role for activity-dependent neurodevelopmental processes during neonatal life. Here, we report the behavioral effects of a novel technique designed to induce targeted, transient disruption of activity-dependent processes in early development via reduction of calcium-mediated neurotransmitter release. We examined the post-pubertal behavioral effects of neonatal (postnatal day 7) medial prefrontal cortex infusion of either vehicle or N-type and P/Q-type presynaptic voltage-dependent calcium channel blockers (omega-conotoxins MVIIA and MVIIC respectively; 6.8 and 45 pmol infused respectively) in rat pups. In a test of amphetamine-induced behavioral sensitization, neonatal omega-conotoxin MVIIA treatment significantly increased locomotion following repeated amphetamine injections (1.5 mg/kg i.p.) and significantly decreased locomotion following repeated saline injections relative to animals treated neonatally with vehicle. However, there was no effect of conotoxin treatment on the long-term expression of amphetamine sensitization. Neonatal treatment with omega-conotoxins had no effect on the other behaviors assayed, namely, acoustic startle response, prepulse inhibition of startle, novelty- and amphetamine-induced (1.5 mg/kg i.p.) locomotion, and anxiety-like behavior in the elevated plus-maze. These data confirm that transient, region-specific disruption of synaptic transmission during early development can have long-term effects on behaviors relevant to neurodevelopmental mental disorders.

    Topics: Aging; Amphetamine; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Calcium Channel Blockers; Calcium Channels; Calcium Channels, N-Type; Calcium Channels, P-Type; Central Nervous System Stimulants; Disease Models, Animal; Drug Interactions; Mental Disorders; Motor Activity; omega-Conotoxins; Prefrontal Cortex; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Reflex, Startle; Synaptic Transmission; Time

2006